U.S. Markets closed

EnteroMedics Inc. (ETRM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
4.98+0.03 (+0.61%)
At close: 4:00PM EDT
People also watch
  • Monster MicroCaps SPECIAL ALERT to ETRM shareholders – NWBO $.19 and climbing, just announced $11 million financing with convertible debt payable in 3 years at $0.25, $.50 and $1.00. NWBO expected to release final Phase III Trial results any day from now until mid-July. If results are comparable to preliminary data, shares likely to explode to yield enormous percentage gains. Announcement could be huge because DCVax-L and DCVax Direct are also proven effective against 13 common cancers and has only mild fever as potential side effect. This breakthrough immunotherapy might replace the $100 Billion chemotherapy market.

    NWBio Closes 3-Year Convertible Debt Exchange and Financing, and Completes Payoff of Last $5 Million of 2014 Bonds
    This completes the Company's payoff of $11 million in principal amount of bonds, plus associated interest and forbearance fees, over the period from March through June of this year in accordance with an installment payment agreement with the bondhold
  • Snatched that profit right back.
  • From the The Sun: PLANET GIRTH Two billion people across the world are obese – with one in four battling fat-related diseases, experts warn


    Two billion people across the world are obese
    MORE than a quarter of the planet’s population is suffering from fat-related health problems, a damning report warns. And four million people died in 2015 as a direct result of being too tubby. Aro…
  • Price Target at $11. I bet u bashers just can't stand to see what real analysts think. Just time now till news hits and we fly to a level way above $10..
  • IGXT (MC $46 M) US-NDA Submission for BLOCKBUSTER Drug this month =1000% Upside Potential ! PLEASE READ THIS

    2 US-NDA submission within 2 months ,lot of Cash and heavily underpriced at $46 million valuation .Load up guys before she the MEGA news hit the wire.Thank me later

    Intelgenx (IGXT)

    MarketCap $46 Million
    Cash untill 2021+ (including convertible debt)
    Price: 0.70

    NDA submission for tadalafil (erectile dysfunction) in June or July
    NDA resubmission for Rizaport (migraine) in early Q3
    Partnership for Tadalafil in 2H 2017


    IntelGenx previously confirmed the bioequivalence of Tadalafil to Eli Lilly’s Cialis, which had sales of $1.5-billion in 2016 but faces generic competition in 2020. IntelGenx has an exclusive license for oral films from Lilly for its dosing patent, which would allow Tadalafil to enter the ED market in the U.S. free from patent litigation from Lilly. Dr. Matzen explains that Tadalafil, which offers a discrete dosing alternative, could enter the market in 2018, with up to three years of market exclusivity before Cialis is hit with generic competition.

    IntelGenx has multi-faceted BD approach for its oral films
    With a burgeoning pipeline of pharmaceutical oral films, IntelGenx’s (OTCQX:IGXT; TSXV:IGX) business development strategy is focused on partnering its product pipeline along with actively meeting with potential partners to explore manufacturing
  • What do you think will happen when they announce they are submitting application for approval of VEST in U.S? :-)
  • All🌱animals🌱are🌱equal🌱-🌱but🌱some🌱animals🌱are🌱more🌱equal🌱than🌱others.http://dataunion.tistory.com/10008

    EnteroMedics Inc NASDAQ $ETRM Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is -0.7 In other words, the correlation coefficient of the other stoc
  • can't believe this garbage is still alive
  • It will be interesting what the next piece of news is and where we go. Rallied off $4.80 with some sustained support.
  • We are starting to see some interest here longs.
  • I think the amount of Enteromedics stock accepted as payment for Vest Systems says a lot about the value of Emteromedics based on a seller that has really understand what the currency/stock is worth that is a large portion of what they are accepting as payment for their company. That makes sense to me. Adds a game changer product in The Vest and adds many many patents to the already indicated 70 that EnteroMedics had as if end of 2016.
  • I really hope these two weight loss techs end up taking market share away from the conventional gastric bypass market. I had mentioned a week or so ago of the people I know that have had gastric bypass surgery only one of them hasn't had any complications. Well that changed. This woman was having chemo for breast cancer. After her second treatment she ended up in ICU due to a ruptured ulcer that the doctors have said was due to the combination of the surgery and chemo. She can't have anymore chemo now. So add that to the list of possible complications of gastric bypass.
  • Cannot believe someone is still buying this garbage after seeing quarterly results and market cap, company sales was 400k only and made huge losses. Nothing but pump and dump! fair value is $0.10!
  • Another pump and dump. Guaranteed.
  • Hopefully big green today!
  • Another meaningless, BS PR to pump the stock price. If you are smart take the opportunity to sell. I promise you can buy back in cheap within a couple of days.
  • Crash on open
  • if u buy yesterday sell today as soon as possible
  • Could pop up to $30 again.
  • This garbage is still trading 5x of its fair value. The last year it has been pumped from $1.40 to $30.00 then back to $6.00. Too many bag holders in here. I mean no news will make it above $6.00 or smth. It will go below $1.00 while longs are leaving one by one. Look at this scam! 40m market cap and the company made 400k revenue only. Market cap has to be 1m. Sorry you are too late to the party, no more gains. However if u r willing you can take huge losses.